Adaptive Biotechnologies (ADPT) Tops Q3 EPS by 7c ; Offers Guidance
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $21.50 --0%
Revenue Growth %: +11.7%
Financial Fact:
Basic (in Shares): -23.01M
Today's EPS Names:
EPAC, SAR, KRUS, More
Revenue Growth %: +11.7%
Financial Fact:
Basic (in Shares): -23.01M
Today's EPS Names:
EPAC, SAR, KRUS, More
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q3 EPS of ($0.22), $0.07 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $46.4 million versus the consensus estimate of $40.21 million.
GUIDANCE:
Adaptive Biotechnologies sees FY2024 revenue of $143-145 million, versus the consensus of $172.1 million.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- China's DeepSeek developing its own AI chip - Reuters
- Alliance Global Partners Downgrades Alarum Technologies (ALAR) to Neutral
- AbbVie updates 2026 EPS guidance after $291M IPR&D charge
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
